Pharmacy

MHE 2020 Annual Pharmacy Survey pt. 3

July 31, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. See a few slides in our third of part three series.

MHE 2020 Annual Pharmacy Survey pt. 2

July 30, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. See a few slides in our second part three series.

MHE 2020 Annual Pharmacy Survey

July 28, 2020

As it has done with so much else in healthcare, COVID-19 dominated our 2020 annual pharmacy survey. The disease was addressed in 10 of our 13 areas we covered, either within the question itself or as a possible answer. See a few slides in our first of part three series.

Opinion: The Future of Pharmacy Care Services, Post-Pandemic

July 27, 2020

Senior Vice President and Chief Pharmacy Officer for Optum Rx and member of the Managed Healthcare Executive® Editorial Advisory Board, David Calabrese, provides his commentary on the future of pharmacy care services after the coronavirus pandemic.

Eric Levin talks PBMs and how Scripta is Tackling the Market's Challenges for Patients

July 22, 2020

MHE's Briana Contreras spoke with CEO of Scripta, Eric Levin. The two discussed the current state of the pharmacy benefit market and how the Scripta organization has been assisting its clients and their prescriptions prior to the COVID-19 pandemic and during.

How COVID has Shaped Consumer Health, Prescription Drug Trends

July 20, 2020

SingleCare analyzed consumer prescription demand and fill data in the weeks leading up to shelter in place orders, beginning in March, and the subsequent months after the pandemic to see how COVID has impacted the healthcare trends of Americans.

Unlocking The Power of Data Intelligence for The Pharmacy

July 13, 2020

From staffing to readmissions to diagnostics, data intelligence is poised to revolutionize healthcare.

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

July 01, 2020

In this week's episode of Tuning Into The C-Suite podcast, MHE's Briana Contreras chatted with David Calabrese, R.Ph, MHP, who is senior vice president and chief pharmacy officer of pharmacy care services company, OptumRx. David is also a member of Managed Healthcare Executives’ Editorial Advisory Board. During the discussion, he shared the OptumRx Quarter 2 Drug Pipeline Insights Report of 2020. Some of the information shared includes the three notable drugs currently being reviewed or those that have been recently approved by the FDA. Also discussed were any interesting industry trends to watch for.

High Hopes for Inclisiran. Will the Third Time be the Charm for PCSK9 Inhibition?

June 22, 2020

The two PCSK9 inhibitors have fallen far short of expectations. Inclisiran, which works by RNA inference, only needs to be injected twice a year. 

4 Ways PBMs are Changing

June 22, 2020

Pharmacy benefit managers are taking steps to be more responsible for the total cost of care and to become more transparent, while adding technology tools to support patients, payers and physicians in a post-COVID-19 world.